ESTRO 2024 - Abstract Book

S2852

Interdisciplinary - Health economics & health services research

ESTRO 2024

comprehensive realignment of education, research design, investment, policy, media, and patient care within the field of oncology.

Results:

The meeting concluded with the official launch of the global CSO movement, driven by a resolute mission and vision. The mission is to ensure that cancer care focuses on outcomes that genuinely matter to patients, transcending geographical and healthcare system disparities. CSO has defined seven guiding principles that revolve around access to cancer care, patient-centered care, defining meaningful endpoints, and prioritizing equitable access to high-quality care. CSO was structured around three core pillars: Evidence Generation (EG), which ensures that clinical trials prioritize and transparently report outcomes that matter to patients; Evidence Interpretation (EI), promoting critical thinking in oncology to enhance the understanding of research findings; Evidence Communication (EC), enhancing the comprehension of cancer treatment options among patients, the public, and policy-makers through clear and accessible communication. It is hoped that improvements in the generation, interpretion, and communication of evidence will ensure that a patient's outcome is not determined by their geographic location, financial means, or marketing efforts. To support these three key pillars, ten projects related to research, education, policy, and advocacy have been launched: three related to EG, five related to EI, and four related to EC. Each project team involves clinicians, academics, and patient advocates.

Conclusion:

CSO aims to improve patients' lives through patient-centered care and equitable access to meaningful cancer treatments. It supports well-conducted trials and effective treatments while challenging harmful interventions. CSO encourages engagement from all stakeholders, particularly patient advocacy groups, and focuses on educating and empowering the next generation of oncologists. The initiative strives to reduce global and regional disparities in accessing affordable, high-quality care. While CSO may evolve, its core mission remains unwavering: prioritizing patient-centered outcomes over commercial interests.

Keywords: value based, capacity building, critical appraisal

2561

Digital Poster

Comparing adaptive IMPT strategies: workload and fraction duration versus dosimetric benefit

Michelle Oud 1,2 , Sebastiaan Breedveld 1 , Marta Giżyńska 2 , Steven Habraken 3,2 , Zoltán Perkó 4 , Ben Heijmen 1 , Mischa Hoogeman 1,2 1 Erasmus MC Cancer Institute, Department of Radiation Oncology, Rotterdam, Netherlands. 2 HollandPTC, Department of Medical Physics & Informatics, Delft, Netherlands. 3 Leiden University Medical Center, Department of Radiation Oncology, Leiden, Netherlands. 4 Delft University of Technology, Department of Radiation Science and Technology, Delft, Netherlands